Search

everythinglearnresearchcommunity

for

Search:↓

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

Drug repurposing shows promise for treating many medical conditions.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The compounds tested could potentially treat hair loss and alopecia.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Companies agreed to stop false advertising about their products' health benefits.

Companies agreed to stop making false health claims about their products.

Scientists recreated human hair follicles in the lab that can grow hair.

Patents don't guarantee money; inventors must work hard and stay involved.

A quick and simple method was created to identify minoxidil in hair-growth products using micellar electrokinetic capillary chromatography.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Human hair follicle stem cells show signs of low oxygen levels, which may be important for hair growth and preventing baldness.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Baldness might be caused by scalp weight pressing on hair follicles.

Combining dutasteride injections with oral minoxidil may improve hair regrowth more than using oral minoxidil alone.

Blocking a protein called prostaglandin D2 might help treat hair loss.

The gel form of substance Y is the most effective for treating hair loss.

A new hair transplant method showed promising results and a study found how deep a CO₂ laser can penetrate skin.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Body hair transplantation is an effective method for restoring hair in people with severe baldness and limited scalp donor hair.